Natural Product (NP) Details
| General Information of the NP (ID: NP8605) | |||||
|---|---|---|---|---|---|
| Name |
6-dehydrogingerdione
|
||||
| Synonyms |
6-Dehydrogingerdione; Dehydro-6-gingerdione; CHEMBL555195; SCHEMBL14952275; CHEBI:81311; C17746; 1-(3-Methoxy-4-hydroxyphenyl)-3-hydroxy-1,3-decadiene-5-one; (1E,3Z)-3-hydroxy-1-(4-hydroxy-3-methoxyphenyl)deca-1,3-dien-5-one
Click to Show/Hide
|
||||
| Species Origin | Zingiber officinale ... | Click to Show/Hide | |||
| Zingiber officinale | |||||
| Disease | Inflammation [ICD-11: N.A.] | Investigative | [1] | ||
| Structure |
|
Click to Download Mol2D MOL |
|||
| ADMET Property |
Absporption
Caco-2 Permeability
-4.94
MDCK Permeability
-4.746
PAMPA
- - -
HIA
- - -
Distribution
VDss
-0.074
PPB
92.9%
BBB
- -
Metabolism
CYP1A2 inhibitor
+++
CYP1A2 substrate
- - -
CYP2C19 inhibitor
+++
CYP2C19 substrate
- - -
CYP2C9 inhibitor
+++
CYP2C9 substrate
+++
CYP2D6 inhibitor
- -
CYP2D6 substrate
++
CYP3A4 inhibitor
++
CYP3A4 substrate
- - -
CYP2B6 inhibitor
+++
CYP2B6 substrate
- - -
CYP2C8 inhibitor
+++
HLM Stability
++
Excretion
CLplasma
7.749
T1/2
0.705
Toxicity
DILI
- - -
Rat Oral Acute Toxicity
- -
FDAMDD
- -
Respiratory
++
Human Hepatotoxicity
-
Ototoxicity
- -
Drug-induced Nephrotoxicity
- -
Drug-induced Neurotoxicity
-
Hematotoxicity
- - -
Genotoxicity
- - -
Tips: 1. For the classification endpoints, the prediction probability values are transformed into six symbols: 0-0.1 (- - -), 0.1-0.3 (- -), 0.3-0.5 (-), 0.5-0.7 (+), 0.7-0.9 (++), and 0.9-1.0 (+++).
2. Additionally, the corresponding relationships of the three labels are as follows: excellent; medium; poor.
Click to Show/Hide
|
||||
| Click to Show/Hide the Molecular Information and External Link(s) of This Natural Product | |||||
| Formula |
C17H22O4
|
||||
| PubChem CID | |||||
| Canonical SMILES |
CCCCCC(=O)C=C(C=CC1=CC(=C(C=C1)O)OC)O
|
||||
| InChI |
1S/C17H22O4/c1-3-4-5-6-14(18)12-15(19)9-7-13-8-10-16(20)17(11-13)21-2/h7-12,19-20H,3-6H2,1-2H3/b9-7+,15-12-
|
||||
| InChIKey |
FZWNRFAUDBWSKY-QNQPVOBRSA-N
|
||||
| ChEBI ID | |||||
| Herb ID | |||||
| SymMap ID | |||||
| TCMSP ID | |||||
| Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
|---|---|---|---|---|---|---|
| α. A List of Drug(s) Whose Efficacy can be Enhanced by This NP | ||||||
| TNF-related apoptosis inducing ligand | Lung cancer | Click to Show/Hide the Molecular Data of This Drug | ||||
| Achieving Therapeutic Synergy | Click to Show/Hide | |||||
| Representative Experiment Reporting the Effect of This Combination | [2] | |||||
| Detail(s) |
Combination Info
click to show the detail info of this combination
|
|||||
| Molecule(s)
Regulation |
Up-regulation | Expression | TRAIL-R2 | Molecule Info |
Pathway MAP
|
|
| In-vitro Model | Hep-G2 | CVCL_0027 | Hepatocellular carcinoma | Homo sapiens | ||
| Experimental
Result(s) |
In addition to the mitochondrial- and Fas receptor-mediated apoptotic pathways involved, ROS-dependent and p53-regulated DR5 expression was also demonstrated to play a pivotal role in the synergistic enhancement of TRAIL-induced apoptosis instigated by 6-DG in Hep G2 cells. | |||||